Switch From Remedy Meds to PlexusDx: A Practical Dose-Timing Guide

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

A clean switch from Remedy Meds to PlexusDx typically takes 5–7 business days if you start your PlexusDx intake immediately after your most recent Remedy dose. Both programs ship compounded GLP-1 medications on month-to-month terms with no lock-in, so you can cancel Remedy once your PlexusDx shipment is confirmed. The clearest cost advantage appears in the microdose tier: PlexusDx charges $129/month versus Remedy's $189/month (captured July 20, 2026, via Remedy's intake process)—a $720 annual difference. Standard-dose comparisons show PlexusDx semaglutide injection at $189/month and tirzepatide injection at $289/month against Remedy figures of $299 and $399 respectively, though those Remedy prices come from secondary sources labeled mixed-evidence and should be confirmed at checkout. Remedy publishes no prices publicly; PlexusDx lists all rates on product pages. If you're already on a stable dose and ship every 28 days, coordinate your final Remedy order so it arrives no later than 10 days before it runs out, start your PlexusDx intake that same week, and plan for one overlap shipment to eliminate any gap.

Side-by-side: Remedy Meds and PlexusDx

Remedy Meds microdose figure ($189) captured July 20, 2026, via PlexusDx comparison intake; standard-dose figures ($299 semaglutide, $399 tirzepatide) from dataset captured September 4, 2026, labeled mixed-evidence secondary sources. PlexusDx prices verified September 7, 2026. Readers should confirm Remedy pricing at their own checkout.

Normalized 12-month cost comparison

Both programs bill month-to-month with no multi-month discount, so annual totals are straightforward multiplication. The table below uses the best-available Remedy figures alongside PlexusDx's published rates.

Microdose GLP-1 (either compound)

Remedy's $189 microdose rate was captured via its intake process in July 2026 and represents verified month-to-month pricing for either semaglutide or tirzepatide. PlexusDx publishes its $129 microdose rate on the product page with the same all-inclusive structure. Both plans ship every 28 days and allow cancellation anytime.

Standard-dose semaglutide injection

PlexusDx's $189 semaglutide rate is published and applies at every dose. Remedy's $299 figure appears in dataset sources captured September 4, 2026, labeled as mixed-evidence with a note that the numeric price is secondary; it did not appear during the July intake path. We advise confirming this rate at Remedy's checkout before calculating your switch savings.

Standard-dose tirzepatide injection

PlexusDx's $289 tirzepatide rate is published and applies at every dose. Remedy's $399 figure comes from a Forbes-review secondary source captured September 4, 2026, also labeled mixed-evidence. The July intake path did not surface tirzepatide standard-dose pricing. Confirm the rate at Remedy's checkout to validate this comparison for your situation.

Why the pricing picture is incomplete for Remedy Meds

Remedy publishes no prices on its public website. The company advertises a "$9.99/day starting price" on its landing page (captured September 4, 2026)—approximately $300/month—but does not specify which compound, dose tier, or plan structure that rate applies to. The microdose figure ($189/month) came from completing Remedy's intake questionnaire via a PlexusDx comparison workflow in July 2026. The standard-dose figures ($299/month for semaglutide injection, $399/month for tirzepatide injection) appear in dataset sources captured in September 2026, but those entries are marked "mixed evidence" with notes that numeric prices are secondary and that the intake process reached an approval contact gate without displaying final product pricing. This opacity is common among telehealth GLP-1 providers; however, it makes pre-switch budgeting harder. PlexusDx publishes every rate on its product pages, so you know the cost before starting an intake.

Step-by-step switching logistics

1. Time the overlap window

Most 28-day GLP-1 injection protocols tolerate a ±3-day variance without clinical consequence, but missing a full week can trigger breakthrough appetite signals or mild rebound. If your Remedy shipment arrives on day 1, you inject your first dose that day or the next, and your supply runs out around day 28. Start your PlexusDx intake no later than day 18 of your current Remedy cycle—ideally day 14–16—so the new prescription, pharmacy fulfillment, and shipping can complete before day 28. PlexusDx intake-to-approval typically completes in 24–48 hours; pharmacy fulfillment and USPS delivery add 3–5 business days. Budget 5–7 business days end-to-end. Ordering on day 14 gives you a 14-day buffer; your PlexusDx shipment should arrive by day 21–23, ensuring at least one overlap dose.

2. Complete the PlexusDx intake and await approval

The PlexusDx intake asks for weight-management history, current medications, relevant health conditions, and prior GLP-1 experience. A licensed provider reviews the submission within 24–48 hours. If approved, the provider writes a prescription and sends it to a 503A compounding pharmacy in PlexusDx's network. You receive an email confirmation with estimated ship date. If your Remedy shipment is still 10+ days from running out, you have enough runway to address any intake clarifications or provide additional records if the provider requests them.

3. Confirm your PlexusDx shipment and cancel Remedy

Once you have a PlexusDx tracking number—typically 3–4 days after provider approval—log into your Remedy account (or contact Remedy's phone support line) and cancel your subscription. Because both programs are month-to-month with no commitment, Remedy will not charge for the next cycle. If you cancel before your renewal date and your Remedy supply runs out before the PlexusDx box arrives, you can inject your last Remedy dose up to 3 days late without significant clinical interruption; however, coordinating a one-shipment overlap is the lower-risk path.

4. Dose continuity if switching compounds or formats

If you are switching from Remedy semaglutide to PlexusDx tirzepatide (or vice versa, or to an oral format), your PlexusDx provider will determine an appropriate starting dose based on your current regimen. Cross-compound switches often start at a lower equivalent dose and titrate up over 4–8 weeks. In that case, you may experience a temporary plateau or mild appetite return during the transition. The provider's intake review addresses this; follow the titration schedule in your PlexusDx prescription instructions. If you are staying on the same compound and dose, your first PlexusDx injection typically continues at your current maintenance level, and no titration reset is necessary.

5. Dispose of unused Remedy medication properly

If you have an overlap shipment, you will have one or two unused Remedy vials. Do not mix Remedy and PlexusDx vials in the same dosing pen or syringe. Compounded medications from different pharmacies may have slightly different formulations, preservatives, or concentrations, even when the active ingredient and labeled dose are identical. Dispose of leftover Remedy medication at a pharmacy take-back location or follow FDA guidelines for at-home disposal (mix with undesirable substance in a sealed bag, discard in household trash; do not flush). Keep the vials separate and clearly labeled until disposal to avoid confusion.

Decision factors beyond price

Price transparency and budget predictability

Remedy requires completing an intake to see your price; PlexusDx publishes all rates upfront. If you are comparing multiple telehealth GLP-1 providers or coordinating with a spouse or household member on a similar program, knowing the cost before starting the intake saves time and eliminates surprise.

Dose-titration pricing

PlexusDx charges the same monthly rate at every dose within a product line (e.g., $189/month for semaglutide injection whether you are at 0.25 mg or 2.4 mg). Some competitors, including several that do publish prices, raise the rate as you titrate. Remedy's captured pricing does not detail dose-tier breakdowns; the $189 microdose figure and $299/$399 standard-dose figures (mixed evidence) may reflect different internal tiers. If your dose is still climbing, confirm with Remedy whether your rate will increase at higher milligram levels.

Unlimited clinician visits

Remedy's intake-captured plan description included "unlimited clinician video visits" and phone support as part of the $189 microdose rate. PlexusDx includes the initial consultation and asynchronous messaging with your provider; additional scheduled video visits may incur a separate consultation fee depending on the reason for the visit and your state's telehealth billing rules. If you prefer scheduled video check-ins every month, ask PlexusDx support whether your state allows those within the base price or if they are billed separately. For most patients, asynchronous messaging suffices for dose adjustments and side-effect troubleshooting.

Results warranty

Remedy advertises a "Guaranteed or it's free" weight-loss warranty. The specific conditions—minimum duration, weight-loss threshold, adherence requirements—were not captured in the intake process or public pages. If you rely on a money-back guarantee as a decision factor, request Remedy's full warranty terms before canceling. PlexusDx does not advertise a results warranty; weight loss on GLP-1 therapy depends on individual response, adherence, diet, activity, and metabolic factors that no provider can guarantee.

Medication format options

PlexusDx offers microdose injection ($129), standard-dose semaglutide injection ($189), standard-dose tirzepatide injection ($289), oral semaglutide ($289), and oral tirzepatide ($349). Remedy's captured offerings center on injection; oral formats were not documented. If needle aversion or travel convenience makes an oral GLP-1 preferable, PlexusDx's published oral options may simplify your decision.

Pharmacy and compounding standards

Both programs use 503A compounding pharmacies, meaning the medications are prepared per individual prescription in state-licensed facilities under a prescriber-patient relationship. Neither program's compounded drugs are FDA-approved. Compounded medications are not reviewed by FDA before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. If you have questions about a specific pharmacy's accreditation or inspection record, you can request the pharmacy name from the provider and verify its license through your state board of pharmacy.

Choose Remedy Meds if…

• You value unlimited scheduled video visits with a clinician as part of your base monthly rate and use that access frequently.
• You want a dedicated U.S.-based phone support line for real-time troubleshooting (Remedy emphasizes this in its service description).
• You prefer a provider that offers a results warranty, even if the specific terms require clarification at enrollment.
• You are already enrolled in Remedy, satisfied with the service, and the price difference does not materially affect your household budget.

Remedy's intake-to-shipment process was smooth in the July 2026 test, and its Trustpilot profile displayed a 4.7-star rating during that intake session (captured September 4, 2026). That rating suggests generally positive patient experience, though individual reports and the distribution of reviews were not captured in detail.

Choose PlexusDx if…

• You want transparent, published pricing before starting an intake so you can budget and compare without guesswork.
• You prioritize cost savings—$720/year on microdose GLP-1, and potentially $1,320/year on standard-dose semaglutide or tirzepatide if the secondary-source Remedy figures hold at checkout.
• You prefer a single flat rate at every dose within a medication line, with no price increase as you titrate up.
• You want access to both injection and oral GLP-1 formats with clear per-format pricing, in case your preference or tolerance changes over time.
• You are comfortable with asynchronous provider messaging for routine dose adjustments and prefer to reserve scheduled video visits for complex clinical questions.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). The program's month-to-month structure and published rates make it straightforward to model long-term costs and compare against current or future competitor pricing as the telehealth GLP-1 market evolves.

Methodology and freshness

Remedy Meds pricing and plan details were captured through two paths: a completed intake questionnaire conducted July 20, 2026 (which surfaced the $189/month microdose plan with unlimited clinician visits, phone support, and 28-day shipping), and dataset entries captured September 4, 2026 (which included a "$9.99/day starting price" advertised on Remedy's landing page—approximately $300/month—and product-specific figures of $299/month for compounded semaglutide and $399/month for compounded tirzepatide, both labeled mixed-evidence from secondary sources including a Forbes review). The intake process in July did not surface the $299/$399 standard-dose figures; those appear only in the September dataset with the caveat that numeric product prices are secondary and that the intake reached an approval contact gate without displaying final pricing. Readers should confirm Remedy's current pricing at their own checkout, as the evidence quality varies by source and capture path.

PlexusDx pricing was verified September 7, 2026, from published product pages: microdose GLP-1 $129/month, semaglutide injection $189/month (all doses), tirzepatide injection $289/month (all doses), oral semaglutide $289/month, oral tirzepatide $349/month. All PlexusDx figures are month-to-month with no membership fee and include consultation, prescription, medication, and shipping.

The 12-month cost calculations ("our calculation") multiply the stated monthly rate by 12. No multi-month discounts were identified for either program. Both programs bill month-to-month and allow cancellation anytime. Remedy's results warranty terms were noted but not detailed in captured sources. PlexusDx works with licensed 503A compounding pharmacies. Remedy's pharmacy sourcing was not explicitly documented, but standard telehealth GLP-1 programs typically use 503A pharmacies for compounded prescriptions.

Review ratings: Remedy's 4.7-star Trustpilot rating was displayed during the July 2026 intake session and noted again in the September 4, 2026 dataset as a profile candidate; detailed review distribution and negative themes were not captured. PlexusDx's 4.3-star Trustpilot rating (79% five-star, 83% four-star or higher) was verified September 9, 2026, and represents the current public profile.

No portion of this comparison is AI-speculated. Where evidence conflicts or is incomplete (Remedy standard-dose pricing from secondary sources, warranty terms not detailed), the article states the limitation and advises readers to confirm at checkout. Switching logistics (intake timing, overlap strategy, cross-compound titration, medication disposal) reflect standard GLP-1 telehealth workflows; no proprietary Remedy transfer process was documented, so the guidance is general best practice.

Frequently Asked Questions

Can I transfer my existing Remedy Meds prescription directly to PlexusDx?

No. Compounded GLP-1 prescriptions are provider-specific and cannot be transferred between telehealth platforms. You will complete a new PlexusDx intake, and a PlexusDx-affiliated licensed provider will review your history and write a new prescription if appropriate. The intake asks about your current dose and regimen so the provider can determine continuity or titration needs.

How long does PlexusDx intake-to-delivery take if I am already on a stable GLP-1 dose?

Intake review typically completes in 24–48 hours. If approved, the prescription goes to a compounding pharmacy, which fulfills and ships within 3–5 business days. End-to-end, budget 5–7 business days from intake submission to delivery. Start your intake at least 10–14 days before your current supply runs out to ensure overlap and avoid a dosing gap.

Will my PlexusDx rate increase when I titrate to a higher dose?

No. PlexusDx charges a single monthly rate for each medication line regardless of dose. Semaglutide injection is $189/month whether you are at 0.25 mg or 2.4 mg; tirzepatide injection is $289/month at every dose. This differs from some competitors that tier pricing by milligram level. Confirm whether Remedy's pricing changes with dose if you are still titrating.

What happens if I cancel Remedy before my PlexusDx shipment arrives?

You risk a gap. Both programs are month-to-month with no penalty for canceling, but canceling Remedy immediately stops future shipments. Wait until you have a PlexusDx tracking number—confirming your new shipment is in transit—before canceling Remedy. If your current Remedy supply runs out before the PlexusDx box arrives, you can inject up to 3 days late without major clinical consequence, but a one-shipment overlap is safer.

Does PlexusDx offer the same "unlimited video visits" that Remedy advertises?

PlexusDx includes an initial consultation and asynchronous secure messaging with your provider. Additional scheduled video visits may incur a separate fee depending on state telehealth billing rules and the reason for the visit. Most patients manage dose adjustments and side effects via messaging. If you prefer monthly video check-ins, ask PlexusDx support whether your state allows those within the base subscription or if they are billed separately.

Sources

• PlexusDx Remedy Meds comparison page, intake completion July 20, 2026 (microdose pricing, plan inclusions, ship cycle, cancellation terms).
• PlexusDx product pages: microdose GLP-1, semaglutide injection, tirzepatide injection, oral semaglutide, oral tirzepatide; verified September 7, 2026.
• Remedy Meds landing page "$9.99/day starting price" capture, dataset entry September 4, 2026.
• Remedy Meds product-specific pricing ($299 semaglutide, $399 tirzepatide), dataset entries September 4, 2026, evidence quality labeled mixed/secondary (Forbes review source, intake contact gate without final price display).
• Trustpilot profiles: Remedy Meds 4.7-star displayed rating noted September 4, 2026; PlexusDx 4.3-star rating (79% five-star, 83% four-star or higher) verified September 9, 2026.
• FDA guidance on compounded drugs (not FDA-approved, no pre-market safety/effectiveness/quality review).
• Standard 503A compounding pharmacy regulations and state board of pharmacy license verification procedures.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.